טוען...
Mycophenolate versus Cyclophosphamide for Lupus Nephritis
Systemic lupus erythematosus is common in our country, and renal involvement is an important cause of chronic kidney disease. This study was aimed at comparing the three regimens, i.e., cyclophosphamide-based regimes (low dose and high dose) and mycophenolate mofetil (MMF)-based regime and determini...
שמור ב:
| הוצא לאור ב: | Indian J Nephrol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5830807/ https://ncbi.nlm.nih.gov/pubmed/29515299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijn.IJN_2_16 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|